[Diagnostic and therapeutic perspectives in RASopathies]

Area of Science:

• Genetics
• Pediatrics
• Oncology

Background:

• RASopathies are congenital disorders presenting in childhood with diverse symptoms affecting neurological, cardiovascular, musculoskeletal, and skin systems.
• These conditions are linked to impaired Ras signaling pathways, disrupting cell growth regulation and increasing tumor predisposition.
• Symptoms include modified growth patterns and potential serious complications.

Purpose of the Study:

• To outline the diagnostic approach for RASopathies.
• To emphasize the importance of genetic counseling and family planning.
• To highlight the availability of targeted therapies for specific organ involvements.

Main Methods:

• Clinical suspicion triggers a stepwise molecular testing approach for RASopathy confirmation.
• Detailed analysis of family history, including four-generation pedigrees, tumor and cardiac involvement, and minor anomalies.
• Post-test genetic counseling is essential for patient management and family planning.

Main Results:

• Molecular testing confirms specific RASopathy diagnoses.
• Pedigree analysis clarifies inheritance patterns for cascade testing.
• Identification of specific organ involvement guides targeted therapeutic interventions.

Conclusions:

• Early diagnosis of RASopathies through molecular testing and genetic counseling is crucial.
• Comprehensive evaluation including pedigree analysis aids in risk assessment and management.
• Timely diagnosis facilitates access to targeted treatments, improving patient outcomes.